Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-29

European Vigilance Network for the Management of Antiviral Drug Resistance

Objective

The overall objective of the viRgil Network of Excellence is to set up the first-ever European Vigilance Network capable of addressing current and emerging antiviral drugs resistance developments. Focusing first on three major diseases (influenza and viral hepatitis B and C), our strategy is to build a sustainable, patient-oriented 'virtual institute' by integrating the currently fragmented European capacities into interacting platforms that together will allow the containment of the problem of viral drug resistance. Being approach- rather than virus- based, the integration process will be flexible enough to embrace in the future drug resistance problems related to other human viruses. Indeed, the proposed complementary platforms will focus each on a topic contributing towards broad objectives: the setting-up of the viRgil clinical platforms (surveillance and virology) will allow a global approach for monitoring, testing and ultimately improving the management of antiviral drug resistance in treated patients, leading to outstanding practices and standards in Europe. Attention will be paid to specific patient communities (children, women). These activities will be strengthened by knowledge generated from the in vitro and in vivo models platform, which will elucidate the mechanisms of the the development of resistance, and from the host determinants platform aiming at understanding patient-related (immune/genetic) factors conditioning viral drug resistance. Platforms dedicated to drugs and pharmacological aspects as well as innovation and technology will enable to anticipate viral resistance against promising drugs closed to clinical application and to overcome future resistance problems by proposing more rational approaches for drug development to the private sector and effective tools for testing resistance to the clinicians. Lastly, viRgil objectives and the benefit for the community will be constantly evaluated by the societal impact platforrm.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2002-LIFESCIHEALTH
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

NoE - Network of Excellence

Coordinator

INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
EU contribution
No data
Address
101 rue de Tolbiac
PARIS
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (57)

My booklet 0 0